ADD TO MY REPORT
You have 0 pages in your custom report
Public Policy and Political Contributions
As a member of the global health care community, we have a responsibility to advance quality health care and work with others to help shape effective health care systems. To do this, we support the development of sound public policy through the policy positions we advocate for and, where political contributions are permitted, the contributions we make to political parties and related institutions.
As reflected in our document, The Promise of Health Care, we consistently lobby for enhancement to health care systems around the globe. We also monitor and engage on business policies, as well as a range of scientific issues.
Johnson & Johnson works in collaboration with many coalitions and partnerships to advance good public policy. In the U.S., we advocate for health care reform, liability reform, creating and preserving jobs, and many other issues. We support a strong and healthy Food and Drug Administration and the disclosure of payments that companies make to physicians. In the European Union, Johnson & Johnson has registered with the European Commission’s European Transparency Initiative to establish a code of conduct for lobbying with EU institutions.
A standing committee of Johnson & Johnson’s Board of Directors, the Public Policy Advisory Committee (PPAC), is responsible for reviewing and making recommendations regarding positions on issues facing the Company. The PPAC is composed of independent directors, the Company’s general counsel, and vice presidents for Corporate Affairs, Government Affairs and Policy, and Worldwide Operations.
As part of Johnson & Johnson’s commitment to transparency, a list of our political contributions can be found here. Johnson & Johnson’s positions on policy issues can be found here.
As reflected in our document, The Promise of Health Care, we consistently lobby for enhancement to health care systems around the globe. We also monitor and engage on business policies, as well as a range of scientific issues.
Johnson & Johnson works in collaboration with many coalitions and partnerships to advance good public policy. In the U.S., we advocate for health care reform, liability reform, creating and preserving jobs, and many other issues. We support a strong and healthy Food and Drug Administration and the disclosure of payments that companies make to physicians. In the European Union, Johnson & Johnson has registered with the European Commission’s European Transparency Initiative to establish a code of conduct for lobbying with EU institutions.
A standing committee of Johnson & Johnson’s Board of Directors, the Public Policy Advisory Committee (PPAC), is responsible for reviewing and making recommendations regarding positions on issues facing the Company. The PPAC is composed of independent directors, the Company’s general counsel, and vice presidents for Corporate Affairs, Government Affairs and Policy, and Worldwide Operations.
As part of Johnson & Johnson’s commitment to transparency, a list of our political contributions can be found here. Johnson & Johnson’s positions on policy issues can be found here.